Combination of microRNA-21 and microRNA-146a Attenuates Cardiac Dysfunction and Apoptosis During Acute Myocardial Infarction in Mice

Molecular Therapy Nucleic Acids

Volumn 5, Issue , 2016, Pages e296-

  Huang, Wei ^a   Tian, Shan Shan ^a   Hang, Peng Zhou ^a   Sun, Chuan ^a   Guo, Jing ^a   Du, Zhi Min ^a,b  

^a HARBIN MEDICAL UNIVERSITY   (China)

^b The University Key Laboratory of Drug Research   (China)

Author keywords

apoptosis; miR 146a; miR 21; myocardial infarction

Indexed keywords

2 MORPHOLINO 8 PHENYLCHROMONE; 4 (4 FLUOROPHENYL) 2 (4 METHYLSULFINYLPHENYL) 5 (4 PYRIDYL)IMIDAZOLE; AGENTS AFFECTING NUCLEIC ACID METABOLISM; APOPTOSIS INHIBITOR; BENZYLOXYCARBONYLASPARTYLGLUTAMYLVALYLASPARTYL FLUOROMETHYL KETONE; CARDIOVASCULAR AGENT; CASPASE 3; CYTOPROTECTIVE AGENT; GLYCERALDEHYDE 3 PHOSPHATE DEHYDROGENASE; MESSENGER RNA; MICRORNA 146A; MICRORNA 146A AGOMIR; MICRORNA 21; MICRORNA 21 AGOMIR; MITOGEN ACTIVATED PROTEIN KINASE P38; PHOSPHATIDYLINOSITOL 3,4,5 TRISPHOSPHATE 3 PHOSPHATASE; PROTEIN KINASE B; SMALL INTERFERING RNA; TUMOR NECROSIS FACTOR RECEPTOR ASSOCIATED FACTOR 6; UNCLASSIFIED DRUG;

ACUTE HEART INFARCTION; ADULT; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTAGONIST POTENCY; APOPTOSIS; ARTICLE; CARDIAC MUSCLE CELL; CELL PROTECTION; CELL VIABILITY; COMBINATION DRUG THERAPY; CONTROLLED STUDY; DRUG EFFICACY; DRUG MECHANISM; DRUG POTENCY; ENZYME ACTIVITY; EXPERIMENTAL MYOCARDIAL ISCHEMIA; GENE EXPRESSION; GENE SILENCING; HEART CONTRACTION; HEART DISEASE; HEART EJECTION FRACTION; HEART INFARCTION; HEART INFARCTION SIZE; HEART INJURY; HEART PROTECTION; HYPOXIA; MALE; MONOTHERAPY; MOUSE; NEWBORN; NONHUMAN; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; RAT; SIGNAL TRANSDUCTION;

EID: 85015666348     PISSN: None     EISSN: 21622531     Source Type: Journal    
DOI: 10.1038/mtna.2016.12     Document Type: Article

References (45)

1. 1 Wartenberg, KE, Malignant middle cerebral artery infarction. Curr Opin Crit Care 18 (2012), 152–163.
2. 2 Bogomolov, AN, Kozlov, KL, Kurochkina, ON, Olesiuk, IB, [Coronary stenting in elderly patients with acute myocardial infarction (review)]. Adv Gerontol 26 (2013), 151–160.
3. 3 Chen-Scarabelli, C, Saravolatz, L Jr, Murad, Y, Shieh, WS, Qureshi, W, Di Rezze, J, et al. A critical review of the use of carvedilol in ischemic heart disease. Am J Cardiovasc Drugs 12 (2012), 391–401.
4. 4 Hojo, Y, Saito, T, Kondo, H, Role of apoptosis in left ventricular remodeling after acute myocardial infarction. J Cardiol 60 (2012), 91–92.
5. 5 Ren, XP, Wu, J, Wang, X, Sartor, MA, Qian, J, Jones, K, et al. MicroRNA-320 is involved in the regulation of cardiac ischemia/reperfusion injury by targeting heat-shock protein 20. Circulation 119 (2009), 2357–2366.
6. 6 Thum, T, Catalucci, D, Bauersachs, J, MicroRNAs: novel regulators in cardiac development and disease. Cardiovasc Res 79 (2008), 562–570.
7. 7 Cheng, Y, Zhu, P, Yang, J, Liu, X, Dong, S, Wang, X, et al. Ischaemic preconditioning-regulated miR-21 protects heart against ischaemia/reperfusion injury via anti-apoptosis through its target PDCD4. Cardiovasc Res 87 (2010), 431–439.
8. 8 Cheng, Y, Liu, X, Zhang, S, Lin, Y, Yang, J, Zhang, C, MicroRNA-21 protects against the H(2)O(2)-induced injury on cardiac myocytes via its target gene PDCD4. J Mol Cell Cardiol 47 (2009), 5–14.
9. 9 Dong, S, Cheng, Y, Yang, J, Li, J, Liu, X, Wang, X, et al. MicroRNA expression signature and the role of microRNA-21 in the early phase of acute myocardial infarction. J Biol Chem 284 (2009), 29514–29525.
10. 10 Sayed, D, He, M, Hong, C, Gao, S, Rane, S, Yang, Z, et al. MicroRNA-21 is a downstream effector of AKT that mediates its antiapoptotic effects via suppression of Fas ligand. J Biol Chem 285 (2010), 20281–20290.
11. 11 Zaman, MS, Shahryari, V, Deng, G, Thamminana, S, Saini, S, Majid, S, et al. Up-regulation of microRNA-21 correlates with lower kidney cancer survival. PLoS One, 7, 2012, e31060.
12. 12 Wang, X, Ha, T, Liu, L, Zou, J, Zhang, X, Kalbfleisch, J, et al. Increased expression of microRNA-146a decreases myocardial ischaemia/reperfusion injury. Cardiovasc Res 97 (2013), 432–442.
13. 13 Brudecki, L, Ferguson, DA, McCall, CE, El Gazzar, M, MicroRNA-146a and RBM4 form a negative feed-forward loop that disrupts cytokine mRNA translation following TLR4 responses in human THP-1 monocytes. Immunol Cell Biol 91 (2013), 532–540.
14. 14 Brudecki, L, Ferguson, DA, McCall, CE, El Gazzar, M, Mitogen-activated protein kinase phosphatase 1 disrupts proinflammatory protein synthesis in endotoxin-adapted monocytes. Clin Vaccine Immunol 20 (2013), 1396–1404.
15. 15 Kasinski, AL, Kelnar, K, Stahlhut, C, Orellana, E, Zhao, J, Shimer, E, et al. A combinatorial microRNA therapeutics approach to suppressing non-small cell lung cancer. Oncogene 34 (2015), 3547–3555.
16. 16 Cheng, Y, Zhang, C, MicroRNA-21 in cardiovascular disease. J Cardiovasc Transl Res 3 (2010), 251–255.
17. 17 Zhu, W, Zhao, Y, Xu, Y, Sun, Y, Wang, Z, Yuan, W, et al. Dissection of protein interactomics highlights microRNA synergy. PLoS One, 8, 2013, e63342.
18. 18 Noguchi, S, Yasui, Y, Iwasaki, J, Kumazaki, M, Yamada, N, Naito, S, et al. Replacement treatment with microRNA-143 and -145 induces synergistic inhibition of the growth of human bladder cancer cells by regulating PI3K/Akt and MAPK signaling pathways. Cancer Lett 328 (2013), 353–361.
19. 19 Dong, CG, Wu, WK, Feng, SY, Wang, XJ, Shao, JF, Qiao, J, Co-inhibition of microRNA-10b and microRNA-21 exerts synergistic inhibition on the proliferation and invasion of human glioma cells. Int J Oncol 41 (2012), 1005–1012.
20. 20 Pisano, F, Altomare, C, Cervio, E, Barile, L, Rocchetti, M, Ciuffreda, MC, et al. Combination of miRNA499 and miRNA133 exerts a synergic effect on cardiac differentiation. Stem Cells 33 (2015), 1187–1199.
21. 21 Porter, AG, Jänicke, RU, Emerging roles of caspase-3 in apoptosis. Cell Death Differ 6 (1999), 99–104.
22. 22 Saikumar, P, Dong, Z, Mikhailov, V, Denton, M, Weinberg, JM, Venkatachalam, MA, Apoptosis: definition, mechanisms, and relevance to disease. Am J Med 107 (1999), 489–506.
23. 23 Tu, Y, Wan, L, Fan, Y, Wang, K, Bu, L, Huang, T, et al. Ischemic postconditioning-mediated miRNA-21 protects against cardiac ischemia/reperfusion injury via PTEN/Akt pathway. PLoS One, 8, 2013, e75872.
24. 24 Szokodi, I, Kerkelä, R, Kubin, AM, Sármán, B, Pikkarainen, S, Kónyi, A, et al. Functionally opposing roles of extracellular signal-regulated kinase ½ and p38 mitogen-activated protein kinase in the regulation of cardiac contractility. Circulation 118 (2008), 1651–1658.
25. 25 Hers, I, Vincent, EE, Tavaré, JM, Akt signalling in health and disease. Cell Signal 23 (2011), 1515–1527.
26. 26 Li, P, MicroRNAs in cardiac apoptosis. J Cardiovasc Transl Res 3 (2010), 219–224.
27. 27 Fernandes-Alnemri, T, Litwack, G, Alnemri, ES, CPP32, a novel human apoptotic protein with homology to Caenorhabditis elegans cell death protein Ced-3 and mammalian interleukin-1 beta-converting enzyme. J Biol Chem 269 (1994), 30761–30764.
28. 28 Salvesen, GS, Caspases: opening the boxes and interpreting the arrows. Cell Death Differ 9 (2002), 3–5.
29. 29 Yang, B, Ye, D, Wang, Y, Caspase-3 as a therapeutic target for heart failure. Expert Opin Ther Targets 17 (2013), 255–263.
30. 30 Marber, MS, Rose, B, Wang, Y, The p38 mitogen-activated protein kinase pathway–a potential target for intervention in infarction, hypertrophy, and heart failure. J Mol Cell Cardiol 51 (2011), 485–490.
31. 31 Ma, XL, Kumar, S, Gao, F, Louden, CS, Lopez, BL, Christopher, TA, et al. Inhibition of p38 mitogen-activated protein kinase decreases cardiomyocyte apoptosis and improves cardiac function after myocardial ischemia and reperfusion. Circulation 99 (1999), 1685–1691.
32. 32 Liu, Y, Zhang, S, Su, D, Liu, J, Cheng, Y, Zou, L, et al. Inhibiting (pro)renin receptor-mediated p38 MAPK signaling decreases hypoxia/reoxygenation-induced apoptosis in H9c2 cells. Mol Cell Biochem 403 (2015), 267–276.
33. 33 Nahid, MA, Pauley, KM, Satoh, M, Chan, EK, miR-146a is critical for endotoxin-induced tolerance: implication in innate immunity. J Biol Chem 284 (2009), 34590–34599.
34. 34 Taganov, KD, Boldin, MP, Chang, KJ, Baltimore, D, NF-kappaB-dependent induction of microRNA miR-146, an inhibitor targeted to signaling proteins of innate immune responses. Proc Natl Acad Sci USA 103 (2006), 12481–12486.
35. 35 Roy, S, Khanna, S, Hussain, SR, Biswas, S, Azad, A, Rink, C, et al. MicroRNA expression in response to murine myocardial infarction: miR-21 regulates fibroblast metalloprotease-2 via phosphatase and tensin homologue. Cardiovasc Res 82 (2009), 21–29.
36. 36 Hlobilková, A, Knillová, J, Bártek, J, Lukás, J, Kolár, Z, The mechanism of action of the tumour suppressor gene PTEN. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub 147 (2003), 19–25.
37. 37 Leslie, NR, Batty, IH, Maccario, H, Davidson, L, Downes, CP, Understanding PTEN regulation: PIP2, polarity and protein stability. Oncogene 27 (2008), 5464–5476.
38. 38 Gratton, JP, Morales-Ruiz, M, Kureishi, Y, Fulton, D, Walsh, K, Sessa, WC, Akt down-regulation of p38 signaling provides a novel mechanism of vascular endothelial growth factor-mediated cytoprotection in endothelial cells. J Biol Chem 276 (2001), 30359–30365.
39. 39 Widenmaier, SB, Ao, Z, Kim, SJ, Warnock, G, McIntosh, CH, Suppression of p38 MAPK and JNK via Akt-mediated inhibition of apoptosis signal-regulating kinase 1 constitutes a core component of the beta-cell pro-survival effects of glucose-dependent insulinotropic polypeptide. J Biol Chem 284 (2009), 30372–30382.
40. 40 Liao, Y, Hung, MC, Regulation of the activity of p38 mitogen-activated protein kinase by Akt in cancer and adenoviral protein E1A-mediated sensitization to apoptosis. Mol Cell Biol 23 (2003), 6836–6848.
41. 41 Yang, B, Lin, H, Xiao, J, Lu, Y, Luo, X, Li, B, et al. The muscle-specific microRNA miR-1 regulates cardiac arrhythmogenic potential by targeting GJA1 and KCNJ2. Nat Med 13 (2007), 486–491.
42. 42 Lu, Y, Zhang, Y, Wang, N, Pan, Z, Gao, X, Zhang, F, et al. MicroRNA-328 contributes to adverse electrical remodeling in atrial fibrillation. Circulation 122 (2010), 2378–2387.
43. 43 Pan, Z, Sun, X, Ren, J, Li, X, Gao, X, Lu, C, et al. miR-1 exacerbates cardiac ischemia-reperfusion injury in mouse models. PLoS One, 7, 2012, e50515.
44. 44 Ai, J, Zhang, R, Gao, X, Niu, HF, Wang, N, Xu, Y, et al. Overexpression of microRNA-1 impairs cardiac contractile function by damaging sarcomere assembly. Cardiovasc Res 95 (2012), 385–393.
45. 45 Chou, TC, Drug combination studies and their synergy quantification using the Chou-Talalay method. Cancer Res 70 (2010), 440–446.